'FDA designation of IQOS as modified risk should change...

adicionou um novo artigo Outro

2021-05-21 04:14:07 -

'FDA designation of IQOS as modified risk should change regulatory regime'

Philip Morris International Korea expects that the U.S. Food and Drug Administration’s designation of IQOS, its heat-not-burn tobacco, as a modified risk tobacco product (MRTP) will prompt a change in the local tobacco regulations.To get more news about Heat not burn, you can visit hitaste.net official website.The FDA grants MRTP status to products that have demonstrated that is...

0 Comentários 0 Compartilhamentos 4607 Visualizações